1. Analyst View
2. Global Generic Drugs Market
2.1 Market Size & Growth
2.2 Performance by Geographical Distribution
3. Brazil Demographics & Healthcare Profile
3.1 Demographics & Macroeconomic Indicators
3.1.1 Macroeconomic Indicators
3.1.2 Population
3.1.3 Life Expectancy
3.1.4 Infant Mortality Rate
3.1.5 Age Breakup
3.2 Healthcare Indicators
3.2.1 Healthcare Structure
3.2.2 Doctors & Hospital Beds
3.2.3 Healthcare Expenditure
3.2.4 Main Causes of Death
4. Brazil Pharmaceutical Market
4.1 Industry Performance
4.1.1 Drug Categories
4.1.2 Market Size & Growth
4.1.2.1 Sales Value
4.1.2.2 Sales Volume
4.1.3 Private & Public Market
4.1.4 Import & Export
4.1.5 Major Pharmaceutical Segments
4.1.6 Investments
4.1.7 Performance of Key Players
5. Brazil Generic Drugs Market
5.1 Market Drivers
5.1.1 Low Cost
5.1.2 Strong Investment
5.1.3 Strong Government Support
5.1.4 Patent Expiries
5.1.5 Ageing Population
5.1.6 Strengthening of Real
5.1.7 Increasing Prescription Rates
5.2 Industry Performance
5.2.1 Market Size & Growth
5.2.1.1 Sales Value
5.2.1.2 Sales Volume
5.2.2 Regulatory Environment
5.2.3 Investments
5.2.4 Performance of Key Players
5.3 Restraints
5.3.1 Dependence on Imported Raw Materials
5.3.2 Over-reliance of Domestic Generic Firms on Domestic Market
5.3.3 Lack of Awareness & Low Prescriptions in Private Sector
5.3.4 Prevalence of ‘Similar Drugs’
5.3.5 Counterfeit Drugs
5.4 Promising Segments in the Generic Business
5.4.1 Antiretroviral
5.4.2 Oral Contraceptives
5.4.3 Erectile Dysfunction
5.4.4 Anti-Thrombotics
5.4.5 Cardiovascular Drugs
5.4.6 Anti-diabetics
6. Future Outlook (2007-2011)
6.1 Pharmaceutical Market
6.2 Generic Drugs Market
7. Profiles of Key Players
7.1 EMS Sigma Pharma
7.2 Medley
7.3 Eurofarma Laboratorios Ltda
7.4 Aché Pharmaceutical Laboratories S/A
7.5 Ranbaxy
.jpg)
